These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 22428002)
1. Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas. McGuire MM; Yatsenko A; Hoffner L; Jones M; Surti U; Rajkovic A PLoS One; 2012; 7(3):e33251. PubMed ID: 22428002 [TBL] [Abstract][Full Text] [Related]
2. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas. Mäkinen N; Vahteristo P; Bützow R; Sjöberg J; Aaltonen LA Int J Cancer; 2014 Feb; 134(4):1008-12. PubMed ID: 23913526 [TBL] [Abstract][Full Text] [Related]
3. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays. Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101 [TBL] [Abstract][Full Text] [Related]
5. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors. Schwetye KE; Pfeifer JD; Duncavage EJ Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187 [TBL] [Abstract][Full Text] [Related]
6. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma. Di Tommaso S; Tinelli A; Malvasi A; Massari S Mol Hum Reprod; 2014 Oct; 20(10):1009-15. PubMed ID: 25015674 [TBL] [Abstract][Full Text] [Related]
7. MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study. Wang L; Hu S; Xin F; Zhao H; Li G; Ran W; Xing X; Wang J Hum Pathol; 2020 May; 99():36-42. PubMed ID: 32240666 [TBL] [Abstract][Full Text] [Related]
8. Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas. Kämpjärvi K; Park MJ; Mehine M; Kim NH; Clark AD; Bützow R; Böhling T; Böhm J; Mecklin JP; Järvinen H; Tomlinson IP; van der Spuy ZM; Sjöberg J; Boyer TG; Vahteristo P Hum Mutat; 2014 Sep; 35(9):1136-41. PubMed ID: 24980722 [TBL] [Abstract][Full Text] [Related]
9. The study of MED12 gene mutations in uterine leiomyomas from Iranian patients. Sadeghi S; Khorrami M; Amin-Beidokhti M; Abbasi M; Kamalian Z; Irani S; Omrani M; Azmoodeh O; Mirfakhraie R Tumour Biol; 2016 Feb; 37(2):1567-71. PubMed ID: 26298726 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation. Corachán A; Trejo MG; Carbajo-García MC; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H Fertil Steril; 2021 Feb; 115(2):512-521. PubMed ID: 33036796 [TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Je EM; Kim MR; Min KO; Yoo NJ; Lee SH Int J Cancer; 2012 Sep; 131(6):E1044-7. PubMed ID: 22532225 [TBL] [Abstract][Full Text] [Related]
12. MED12 alterations in both human benign and malignant uterine soft tissue tumors. Pérot G; Croce S; Ribeiro A; Lagarde P; Velasco V; Neuville A; Coindre JM; Stoeckle E; Floquet A; MacGrogan G; Chibon F PLoS One; 2012; 7(6):e40015. PubMed ID: 22768200 [TBL] [Abstract][Full Text] [Related]
13. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids. Halder SK; Laknaur A; Miller J; Layman LC; Diamond M; Al-Hendy A Mol Genet Genomics; 2015 Apr; 290(2):505-11. PubMed ID: 25325994 [TBL] [Abstract][Full Text] [Related]
14. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Mäkinen N; Mehine M; Tolvanen J; Kaasinen E; Li Y; Lehtonen HJ; Gentile M; Yan J; Enge M; Taipale M; Aavikko M; Katainen R; Virolainen E; Böhling T; Koski TA; Launonen V; Sjöberg J; Taipale J; Vahteristo P; Aaltonen LA Science; 2011 Oct; 334(6053):252-5. PubMed ID: 21868628 [TBL] [Abstract][Full Text] [Related]
15. Genomics of uterine leiomyomas: insights from high-throughput sequencing. Mehine M; Mäkinen N; Heinonen HR; Aaltonen LA; Vahteristo P Fertil Steril; 2014 Sep; 102(3):621-9. PubMed ID: 25106763 [TBL] [Abstract][Full Text] [Related]
16. Frequency and Spectrum of MED12 Exon 2 Mutations in Multiple Versus Solitary Uterine Leiomyomas From Russian Patients. Osinovskaya NS; Malysheva OV; Shved NY; Ivashchenko TE; Sultanov IY; Efimova OA; Yarmolinskaya MI; Bezhenar VF; Baranov VS Int J Gynecol Pathol; 2016 Nov; 35(6):509-515. PubMed ID: 26630226 [TBL] [Abstract][Full Text] [Related]
17. Mutation status of the mediator complex subunit 12 (MED12) in uterine leiomyomas and concurrent/metachronous multifocal peritoneal smooth muscle nodules (leiomyomatosis peritonealis disseminata). Rieker RJ; Agaimy A; Moskalev EA; Hebele S; Hein A; Mehlhorn G; Beckmann MW; Hartmann A; Haller F Pathology; 2013 Jun; 45(4):388-92. PubMed ID: 23635816 [TBL] [Abstract][Full Text] [Related]
18. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas. Galindo LJ; Hernández-Beeftink T; Salas A; Jung Y; Reyes R; de Oca FM; Hernández M; Almeida TA Gynecol Oncol; 2018 Sep; 150(3):562-568. PubMed ID: 30017537 [TBL] [Abstract][Full Text] [Related]
19. MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma. Bertsch E; Qiang W; Zhang Q; Espona-Fiedler M; Druschitz S; Liu Y; Mittal K; Kong B; Kurita T; Wei JJ Mod Pathol; 2014 Aug; 27(8):1144-53. PubMed ID: 24390224 [TBL] [Abstract][Full Text] [Related]